Conciliação medicamentosa e revisão da farmacoterapia em oncopediatria: ações efetivas para prevenção de erros

Abstract

Medication errors in oncopediatry affect the chemotherapy treatment of prolonging hospitalization time, aggravate adverse reactions and the results in the patient, and are not desirable for the child-juvenile patient. Being a public where they are tested the viruses are very limited, they compete with a Clinical Pharmacy, an identification and identification of medication errors that can occur during the prolonged chemotherapy treatment of inpatients. This study was carried out with the objective of clarifying the diagnosis of mental disorders in patients hospitalized at a reference hospital in oncopediatrics in the north and northeast regions. 87.5% were diagnosed with 65% of patients with stable outcome status and 35% resolved status. In addition, 236 drugs were reconciled, identifying 51% of discrepancies, 90% being unintentional and 100% acceptability of the data. Based on the data, it is possible that the proportion of drug reconciliation and review of drugs are important to prevent errors and promote capacity reduction during the chemotherapy treatment of the child with cancer.